Armistice Capital, LLC 13D/13G Filings for Can-Fite BioPharma Ltd. (CANF)

Armistice Capital, LLC 13D and 13G filings for Can-Fite BioPharma Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
5:33 pm
Sale		 2024-12-31 13G Can-Fite BioPharma Ltd.
CANF		 Armistice Capital, LLC 440,422
4.990%		 -238,108decrease
(-35.09%)		 Filing
2024-11-14
4:48 pm
Purchase		 2024-09-30 13G Can-Fite BioPharma Ltd.
CANF		 Armistice Capital, LLC 678,530
9.990%		 24,584increase
(+3.76%)		 Filing
2024-02-14
3:32 pm
Purchase		 2023-12-31 13G Can-Fite BioPharma Ltd.
CANF		 Armistice Capital, LLC 653,946
9.990%		 653,946increase
(New Position)		 Filing